## Abstract ## BACKGROUND The clinical value of positron emission tomography (PET) with [^18^F]fluoro‐2‐deoxy‐D‐glucose (FDG) for primary staging in cervical carcinoma appears to be promising. The authors sought to evaluate the diagnostic efficacy and benefit of PET in restaging cervical carcinoma
A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma
✍ Scribed by Carmen R. Isasi; Ping Lu; M. Donald Blaufox
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 102 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Positron emission tomography (PET) with 2-deoxy-2-fluoro[ 18 F]-Dglucose (FDG) can provide quantitative information about tumor glucose metabolism. The prognostic value of this technique was evaluated for breast carcinoma patients. ## METHODS. FDG PET was performed on 70 patients w
^18^F‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/PET‐computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG‐PET in predicting the prognosis for p